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Objective: the relationship between Quality of life (QoL) and global functioning and symptoms in outpatients with
Schizophrenia
Method: The study was carried out on the outpatients with schizophrenia attending a Community Mental Health
Centre in 2008. Each patient completed the WHO QoL Instrument - Brief and was administered the Brief Psychiatric
Rating Scale-24 to assess psychiatric symptoms and the VADO Personal and social Functioning Scale to assess the
level of functioning.
Results: subjects showed an intermediate satisfaction on the overall QoL and health; these data can be juxtaposed
to the national standard sample rates. QoL resulted positively associated to personal and social functioning, while it
was negatively related to psychiatric symptoms.
Conclusion: patients showed a fairly good satisfaction in regard to their QoL. The severity of psychiatric symptoms
is one of the elements influencing QoL, together with personal and social functioning that plays a relevant role.
Introduction
A specific interest regarding quality of life of patients
with schizophrenia dates back to the de-institutionalisa-
tion process which took place in the 1960 s and 1970 s
in several western countries [1,2]. In fact, as a result of
mental health reforms, the effects of the shift of care
from asylum to community health centres became a
necessity for clinicians, researchers and health policy
makers.
It was apparent that capturing psychopathological
symptoms alone was not sufficient to reflect relevant
outcomes. In particular, information on the social func-
tioning and quality of life are regarded as essential for
evaluating long-term outcomes.
Quality of life may be defined as a person’ss e n s eo f
wellbeing and satisfaction with his/her life circum-
stances, as well as a person’s health status and access to
resources and opportunities [3]. Clearly, such an out-
come is of particular importance in order to develop
treatments that can help individuals with schizophrenia
to lead more fulfilling and satisfying lives [4].
Unfortunately, factors influencing QoL in schizophre-
nia are not well known. Studies addressing QoL for
patients with schizophrenia and other severe mental ill-
nesses have identified a number of important influential
factors, such as social support [5], unmet needs, [6] and
medication side effects [7].
However, most of the research examining factors
affecting QoL has primarily focused on the impact of
psychiatric symptoms. Some studies found from small
to moderate relationships between psychiatric symptoms
a n dQ o L[ 8 , 9 ]w h i l eo t h e r sp r e s e n t e df i n d i n g ss u g g e s t -
ing that certain aspects of these concepts may be indis-
tinguishable [10,11], particularly as far as negative
symptoms and general psychopathology (eg, anxiety,
depression) are concerned [4]. In recent years, several
research groups have concluded that the so-called nega-
tive symptoms of schizophrenia are much more closely
related to quality of life than positive symptoms [12,13].
In a study of 128 patients, Norman et al. [11] have
examined the relationship of symptoms and level of
functioning in schizophrenia to the quality of life: their
results show that negative symptoms, level of function-
ing and positive symptoms all were related to the Qual-
ity of Life Scale.
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et al. [10] showed that subjectively reported life satisfac-
tion was not related to positive or negative symptoms of
schizophrenia but did correlate with depressive symp-
toms. A study in five European centres [6] measuring
QoL and other patient and illness characteristics in a
group of 143 outpatients with schizophrenia, found that
patient’s QoL is predicted mainly by anxiety and depres-
sion and by global functioning.
These variations among studies appear to be at least
partially due to differences in the definition and mea-
surement of QoL [14], given the complexity and hetero-
geneity of the concept of quality of life [15]. Some
definitions of QoL refer to it as a multidimensional set
of components consisting of a person’s [1] satisfaction
with his/her life as a whole, or general wellbeing; [2]
observable social and material wellbeing, or objective
QoL; [16] satisfaction with his/her social and material
wellbeing, or subjective QoL; and [17] health and func-
tional status, or health-related QoL [3]. Clarifying the
relationship between psychiatric symptoms, global func-
tioning and QoL represents an important step both in
elucidating factors affecting QoL for individuals with
schizophrenia and in understanding the utility of the
concept of QoL for guiding future treatment develop-
ment efforts [4].
Italy has implemented a decentralisation of its mental
health services since 1978 with a major function in psy-
chiatric care being placed in the Community Mental
Health Centres (CMHC) that provide psychiatric inte-
grated interventions in different settings, including out-
patients clinics, and patients’ own homes [18].
The aim of the present study was to assess the out-
comes in all subjects with schizophrenic diagnosis
attending a Community Mental Health Centre in Cop-
paro (Ferrara-Italy) and to examine the relationships




The present study was carried out from August to Sep-
tember 2008 in a Community Mental Health Centre,
Copparo, of the Integrated Department of Mental
Health in Ferrara, Emilia-Romagna Region, Northern
Italy. Since the creation of the Department of Mental
Health and the implementation of the psychiatric ser-
vices after the 1978 reform in the Emilia-Romagna
Region [18], community mental health centers have
played a central role in delivering integrated care for
patients with schizophrenia and their families.
Copparo Center is the health facility to which 37.803
inhabitants refer to, 19678 females and 18125 males;
4051 are under 18 and 10526 are over 65. Population is
spread over 6 municipalities and mainly works in agri-
cultural, commercial and industrial activities, in a flat
countryside, well-supplied with facilities.
The Center is made up by an outpatient department
and a day-hospital, both open eight hours a day on
working days; it provides medical examinations and
home consulting, drug therapies whenever needed,
group therapies, individual and group rehabilitations
activities, meetings with family members. Compulsory
psychiatric hospitalizations for acute illnesses are made
by the Psychiatric Unit of Ferrara Hospital, which is 18
km far, while voluntary hospitalizations for severe ill-
nesses use both Ferrara and Lagosanto Hospital Units,
30 km far. Both units provide 15 beds, for the whole
district, with 351463 caseload.
Rehabilitating hospitalizations, with projects from 1 to
3 months, are made in specific district facilities. There
are three residences, providing 50 beds.
The Centre staff is composed by 6 psychiatric nurses,
2 psychiatrists, 1 psychologist and 1 social worker. The
Centre deals with any sort of psychiatric illness, from
reactive forms to psychoses, and supplies consulting at
the local hospital and cooperates with family doctors
and with the Department for Drug Abuse, which is in a
different building. All subjects, even non-residents, have
the right to receive free assistance, paying simply a
money contribution. Subjects with a low income or with
severe illnesses don’t pay the money contribution. Schi-
zophrenic subjects have totally free assistance.
Criteria for the inclusion in the study were: a) being
outpatients at the CMHC; b) a diagnosis of schizophre-
nia according to the WHO-ICD-10 classification (F20.0
- F20:9) [19] c) age above 18 years.
Each patient was contacted by a research psychiatrist
and a visit scheduled into the outpatient clinic of the
CMH service, informed consent according to the Local
Ethical Committee was gathered during the meeting.
A series of instruments were used to assess psycho-
pathology, level of functioning and quality of life.
The World Health Organization Quality of Life - Brief
(WHOQoL-Bref) was used to assess the patients’ quality
of life. The WHOQoL-BREF includes 26 items measur-
ing the following domains: physical health, psychological
health, social relationships, and environment. Two
further items evaluate the individual’s overall perception
of quality of life and the individual’s overall perception
of their health. Domain scores are scaled in a positive
direction (i.e. higher scores correspond to better quality
of life). The average score of items within each domain
is used to calculate the domain score. Mean scores are
then multiplied by 4 in order to make domain scores
comparable with the scores used in the WHOQOL-100.
Where more than 20% of data is missing from an
assessment, the assessment should be discarded. Where
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domain is substituted. Where more than two items are
missing from the domain, the domain score should not
be calculated (with the exception of domain 3, where
t h ed o m a i ns h o u l do n l yb ec a l c u l a t e di f<1i t e mi s
missing) [16].
The VADO Personal and Social Functioning Scale
(FPS), which is a modified version of the Social and
Occupational Functioning Assessment Scale (SOFAS)
[17], was used to assess the patients’ level of functioning
in four main areas: work and/or socially useful activities;
family, personal and social relationships; self-care;
aggressive and destructive behaviours. Suicide risk is
considered in the score only as much as suicidal rumi-
nations may interfere with social-functioning. The FPS
requires a brief and simple training, that is described in
the VADO manual [20]. An evaluation is assessed
according to the following levels: absent, slight, evident,
marked, severe. The evaluation is then turned into a
score from 0 to 100 (higher scores correspond to better
functioning) according to VADO guide instructions.
In the present study, separate evaluations were carried
out by two psychiatrists with training in the administra-
tion of the scale.
The Italian version of Brief Psychiatric Rating Scale
(BPRS), in its 24-item 4.0 version [21,22] was used to
assess psychiatric symptoms.
Each item is rated on a seven-point Likert scale (from
1 = no symptom to 7 = extremely severe symptom -
range score = 24-168), yielding four factors: positive
symptoms (items 9-12, 14-15, and 24), negative symp-
toms (items 13, 16-18, and 20), anxiety and depression
(item 1-5, and 19), mania and hostility (items 6-8. and
21-23).
Statistical Analysis
Statistic analysis was carried out using the SPSS 12.0
and Winstat for Excel statistic systems. Statistic proce-
dure included the following survey: descriptive statistics,
variation in answer distributions (frequencies), Pearson r




The study was proposed to all the 107 subjects of the
Centre: 3 subjects, 2 women over 70, and a man who
was 36 years’old refused to participate.
The characteristics of the subjects participating in the
study are reported in Table 1. The sample consisted of
104 patients, of whom 62 males (59,6%) and 42 females
(40,4%) with a mean age of 47 years (SD 13.5) The
mean age of first contact with the CMH was 33.3 years
(SD 13.6), and the duration of illness 13.4 years
(SD 7.4). Distribution by age groups is shown in figure
1. 32 of the subjects (30.7%) were employed, 4 (3.8%)
unemployed, 6 (5.7%) retired and 62 (59.6%) had a dis-
ability pension. 89 (85.6%) lived in their own house,
while the rest lived in a group home, boarding home, or
halfway house. 40 (38.5%) had a partner and 64 (61.5%)
were single.
2 subjects had no therapy, 20 subjects were under
typic antipsychotics therapy, 54 atypics antipsychotics
and 28 depot antipsychotics (26 of them were atypics).
The average hospitalization rate is 18.0 days per year
of disease in males, 7.3 days per year in females.
On average, males had 54.15 ambulatory interventions,
females 39.1; ambulatory interventions include examina-
tions, conversations, group or family therapy meetings,
with both nurse and doctor staff members.
32 males (51.6%) have attended a Day Center for at
least a month, whereas only 12 females have (28.5%).
Outpatients in the past had 50 compulsory admissions
in males, out of 358 admissions (13.97%), and 15 for
females, out of 254 admissions (5.9%). Hospital admis-
sions in the latest year were 8, divided among 6 persons,
5 males e 1 female: a man had three hospitalizations in
a year, 5 subjects were undergoing a 6-months residen-
tial rehabilitation program.
Quality of Life
Table 2 shows the mean scores related to every item of
the four domains of the WHOQoL-BREF. In the first
two items of the test, quality of life perception (Q1)
recorded a 3.21 (SD 0.94) average score and 3.14 mean
score on the perception of one’s own health (Q2), corre-
sponding to “neither satisfied nor dissatisfied”.T o t a l
mean scores of the four domains show a higher level of
satisfaction on physical and environmental health
domain, while a lower level of satisfaction emerged in
social relations domain.
In table 3 the scores of the first 2 items and of the
four domains are presented separately for men and
women and by age groups (< 45 years and ≥ 45 years).
Males’ scores reveal a higher level of satisfaction than
females’ scores in all domains except domain 3 (social);
males who were over 45 showed a wider quality of life
perception (Q1) and perception of one’so w nh e a l t h
(Q2) than younger males, and show a better QoL in
social and environmental relations; they show, however,
a lower satisfaction in physical and psychological
domain. Among the females, the group aging over 45
declared a lower satisfaction than the younger ones in
all WHOQoL domains. Regarding physical health, differ-
ences between sexes and ages are statistically significant
(p < 0.05).
Scores were later turned into 0-100 scale according to
specific guidelines, and compared to average of the
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comparison showed that sample subjects had a lower
degree of satisfaction in social relations and psychologi-
cal domain; however, greater satisfaction in environmen-
tal and physical domain emerged. (Figure 2)
Psychiatric symptoms and global functioning
Average score obtained by symptoms survey through
BPRS was 47.3 (SD 18.1; range from 24 to 110). Accord-
ing to the BPRS cut-off score, 12.5% of subjects had a
BPRS >72, 27.9% between 49 and 72, and 59.6% ≤48.
Table 4 shows average scores obtained by the four sub-
scales characterising BPRS. The total average score
obtained in anxiety-depression subscale is 12.88 (SD
5.9), in positive symptoms is 21.02 (SD 5.3), in negative
symptoms is 13.41 (SD 7.2) and in mania-hostility 10.39
(SD 5.3).
Average scores obtained by Personal and Social Func-
tioning Scale are presented in Table 4; total average
score is 55.35 (SD 22.4), ranging from 11 to 100. 31.7%
of subjects had severe or very severe social difficulties
(FPS ≤ 40), 24% had marked difficulties (FPS 41-60),
34.6% had plain or light difficulties (FPS 61-80) and
9.6% had very light or no difficulties at all (FPS >80). In
the 4 domains examined by FPS, most difficulties were
found in work and socio-relational functioning (diffi-
culty degree mostly between light and plain), followed
by self-care and health domain, and finally in disturbed
and aggressive behaviours, where only light or no diffi-
culties at all are recorded.
Variables associated with QoL in patients with
schizophrenia
Correlations between WHOQoL, BPRS and FPS are
shown in table 5.
WHOQoL results related to FPS total score and sub-
scales, especially health and environment satisfaction
scales. Personal and social functioning is related negatively
to the “health satisfaction” -WHOQoL domain 1 (r = 0.57;
p < 0.0005), to the “social relationships satisfaction”
-WHOQoL domain 3 (r = 0.37; p < 0.05) and to the"
environment satisfaction” -WHOQoL domain 4 (r = 0.43;
p<0 . 0 0 0 5 ) .
Patients’ age was also negatively correlated to QoL,
particularly to “health satisfaction” (r = - 0.35; p <
Table 1 Socio-demographic characteristics of the sample (n =104)
Male Female Total
Number (%) 62 (59.6%) 42 (40.4%) 104
Age at 2008 (years) 44.9 ± 12.2 51.9 ± 12.5 47.0 ± 13.5
Age at T0* (years) 31.0 ± 11.4 37.9 ± 12.8 33,3 ± 13.6
Length of illness (years) 13.2 ± 7.1 13.5 ± 7.1 13.4 ± 7.37
Hospitalization rate Dd/year 18.0 ± 43.7 7.3 ± 62.8
Outpatient intervention n/year 54.15 ± 52.8 39.1 ± 46.6
Marital status Single 64 61.5%
Partner 40 38.5%
Housing Private house 89 85,6%
Group home/Boarding home/halfway house 15 14,4%




*T0 age = age when first arrived at Mental Health Department
      
Figure 1 Distribution by age groups.
Table 2 Perceived quality of life survey: mean scores on
WHOQoL-BREF single items and mean scores on
WHOQoL-BREF four domains






Domain 1 (Physical) 3.26 (0.74) 22.8 (5.2)
Domain 2
(Psychological)
2.98 (0.52) 17.8 (3.2)
Domain 3 (Social) 2.43 (0.98) 7.2 (2.9)
Domain 4 (Environment) 3.06 (0.70) 24.4 (5.6)
Q1 = Overall perception of QoL; Q2 = Overall perception of Health
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0.12; p < 0.05); similarly disease length was negatively
correlated to “health satisfaction” (r = - 0.18; p < 0.05).
Global functioning in our subjects (FPS tot) resulted
negatively related to symptoms (BPRS tot), in particular
to negative symptoms with a marked negative correla-
tion (r = - 0.65; p < 0.0005).
Significant correlations between negative symptoms
(BPRS negative symptoms) and “physical area"-WHO-
QoL domain 1 (r = 0.29; p < 0.05) and “environment
domain"-WHOQoL domain 4 (r = 0.16; p < 0.05) were
found; general psychopathology (BPRS anxiety-depres-
s i o n )w a sr e l a t e dt o“psychological domain"-WHOQoL
domain 2 (r = - 0.28; p < 0.05), to the"social domain"-
WHOQoL domain 3 (r = - 0.15; p < 0.05) and to the
individual’s overall perception of QoL -Q1 (p = -0.32; p
< 0.05); also positive symptoms (BPRS positive symp-
toms) had correlation to “social domain"-WHOQoL
domain 3 (r = - 0.15; p < 0.05) and individual’so v e r a l l
perception of QoL (p = - 0.17; p < 0.05).
Discussion
In the present study we examined all the subjects with a
diagnosis of schizophrenia attending the same Commu-
nity Mental Health Centre in Northern Italy. Taking
into account schizophrenia outcome variability [24-26],
psychiatric symptoms and overall functioning and qual-
i t yo fl i f ew e r ea s s e s s e di no r d e rt ov e r i f yt h er e l a t i o n -
ship between these variables and quality of life.
First, findings obtained through self-administered
WHOQoL-BREF suggest that quality of life is not
extremely negative, though schizophrenia is often an
impairing chronic illness. In some respects, the popula-
tion studied obtained higher scores on environment
and physical dimensions of the WHO-QoL-Bref than
average of the national Italian WHOQoL validation
group.
With aging, perceived physical health quality gets
worse, probably in relation to the increase of such dis-
eases as hypertension, diabetes and rheumatic diseases,
that were recorded in our analysis. Curiously enough, as
the disease length increases, perceived QoL does not get
worse, on the contrary, overall QoL gets better. This
could be caused by an increased knowledge of the dis-
ease and its treatment possibilities.
In WHOQoL single items scoring, major insatisfac-
tions regard sexual life (absolutely nonsatisfying for
59.7% of males and 54.7% of females), working life
(54.8% of males and 50% of females are totally unsatis-
fied of their working life);
The relation with the health department, including
mental health service, is considered negatively only by
12.9% of males and 0.5% of females, a flattering result
for the staff members; over 70% of the subjects declare
to be satisfied with the environments where they live
and of the facilities that are provided.















2.22 (0.89) 2.19 (0.95) 21.75 (5.33) 13.85 (4.48) 4.00 (2.62) 16.77 (5.26)
Men
≥ 45 years
2.39 (0.89) 2.43 (0.94) 20.30 (6.56) 13.69 (4.93) 4.56 (2.95) 17.78 (5.72)
Women
< 45 years
2.27 (1.16) 2.33 (0.97) 22.53 (5.78) 14.13 (3.97) 5.80 (3.00) 15.93 (5.83)
Women
≥ 45 years
1.95 (1.04) 1.62 (0.94) 16.46 (6.28) 11.67 (4.90) 3.42 (2.83) 15.50 (5.67)
Men Total recorded
range
2.29 (0.87) 2.29 (0.93) 21.05 (5.87) 13.73 (4.59) 4.17 (3.20) 16.95 (5.64)
Women Total recorded
range
2.12 (1.09) 1.95 (1.02) 19.1 (6.97) 12.8 (4.82) 4.47 (3.20) 15.87 (5.81)








Physical Psychological Social Environment
Quality of Life (WHOQoL-BREF)
Patients with schizophrenia Control
Figure 2 A survey on the perceived quality of life through
WHOQoL-BREF: mean scores obtained in the four domains and
comparison with Control of Italian WHOQoL-BREF Validation
Group.
Galuppi et al. International Journal of Mental Health Systems 2010, 4:31
http://www.ijmhs.com/content/4/1/31
Page 5 of 8In our study the psychiatric symptoms and overall
functioning resulted diversified, as one third of subjects
showed severe or extremely severe functioning difficul-
ties. Consistently with literature [25,27], this suggests
that schizophrenia is an extremely heterogeneous illness
with many possible variables influencing psychopathol-
ogy and disability.
Regarding the association of psychiatric symptoms and
global functioning to QoL, we found a statistically sig-
nificant correlation between BPRS and quality of life.
Literature shows a great variability among studies on
symptoms and QoL in schizophrenia, mostly due to
wide variations in measurement strategies and defini-
tions of QoL. Fitzgerald et al. [10], in a study comparing
subjective to observer-rated QoL in schizophrenia,
showed how subjective reported life satisfaction, mea-
sured with “SCAP instrument” (which is a 100-item self-
report instrument that contains a number of items of
self-report life satisfaction) was not related to positive or
negative symptoms, but was correlated with depressive
symptoms. Ross et al. [11], in a study on QoL, symp-
toms and level of functioning in schizophrenia, suggest
that QoL in schizophrenia is more highly related to
negative rather than positive symptoms. Weighted effect
size analyses revealed small relationships between psy-
chiatric symptoms and QoL, with general psychopathol-
ogy showing the strongest negative associations across
all QoL indicators [4].
In our study, we found a statistically significant corre-
lation between symptoms and quality of life. More
symptomatic subjects haveaw o r s ep e r c e p t i o no fQ o L .
Especially anxiety-depression symptoms determine a
worse evaluation of general QoL, satisfaction own health
and psychological health, whilst negative symptoms are













BPRS total mean (S.D.)
Men
< 45 years
12.6 (6.41) 11.3 (6.42) 12.55 (5.53) 11.31 (5.81) 48.72 (19.86)
Men
≥ 45 years
11.96 (4.79) 9.83 (4.53) 13.96 (7.4) 8.87 (3.15) 44.61 (14.22)
Women
< 45 years
14.87 (6.6) 9.87 (4.8) 11.7 (6.15) 10.86 (4.75) 47.92 (14.92)
Women
≥ 45 years
12.78 (5.92) 8.56 (3.64) 14.52 (8.92) 9.82 (5.29) 46.04 (17.47)













1.75 (1.49) 1.74 (1.11) 1.24 (1.23) 0.62 (1.24) 57.75 (20.82)
Men
≥ 45 years
2.28 (1.66) 2.0 (1.39) 2.04 (1.47) 0.52 (1.01) 52.35 (24.08)
Women
< 45 years
1.07 (1.64) 2.03 (1.39) 1.5 (1.05) 1.1 (1.5) 53.87 (23.01)
Women
≥ 45 years
1.87 (1.52) 2.02 (1.38) 1.56 (1.37) 0.69 (1.27) 56.65 (22.14)
Total recorded range 0-4 0-4 0-4 0-4 11-100
Table 5 Correlation between global functioning, symptoms and Quality of life (n = 104)
Q 1 Q 2 WHOQoL domain 1 WHOQoL domain 2 WHOQoL domain 3 WHOQoL domain 4
Age in 2008 -0.04 -0.09 -0.35** -0.21* -0.12* -0.08
Disease length 0.19* 0.07 -0.18* -0.06* 0.04 -0.05
FPS total 0.28* 0.30* 0.57** 0.34* 0.37* 0.43**
BPRS anxiety-depression -0.32* -0.29* -0.08 -0.28* -0.15* -0.05
BPRS positive symptoms -0.17* -0.16* -0.08 -0.10* -0.15* -0.10*
BPRS negative symptoms -0.06 -0.13* -0.29* -0.08 -0.10* -0.16*
BPRS mania-hostility -0.22* -0.25* -0.06 -0.13* -0.14* -0.03
BPRStot -0.25* -0.28* -0.20* -0.20* -0.19* -0.12*
*p < 0.05 **p < 0.0005
Q1 = Overall perception of Quality of Life; Q2 = Overall perception of Health
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These results agree with what reported by other authors
[10,11,28].
Major statistically significant correlations of QoL
regarded overall functioning; most correlations were
found between all subscales of FPS and WHOQoL
domain 1 (physical area), and domain 4 (environment),
while lower, even if statistically significant, correlations
were shown between FPS tot and WHOQoL domains 2
and 3 (psychological and social). As the level of personal
and social disability increases, the dissatisfaction about
physical health, environment, social and eventually psy-
chological aspects increases, in an overall unsatisfaction
about QoL.
These results point out how personal and social func-
tioning plays a key role, in schizophrenia, in determining
subjects’ quality of life, while symptoms, though related
t oQ o L ,d on o ts e e mt ob et h em a j o rv a r i a b l ei nm o l d -
ing QoL.
Psychiatric symptoms also were found to be negatively
associated with overall functioning. The results of a
cross-sectional study using data from a large study [29]
suggested similarly that symptoms may be strongly
related to functioning [30]. According to our data, a
major highly significant correlation is related to negative
symptoms and functioning measured through FPS (r =
0.65; p < 0.0005). These findings confirm the well-docu-
mented strong relationship between negative symptoms
and social disability [31-33].
Certain limitations of the study should be mentioned.
First, the study was cross-sectional; therefore, the
exploration of causal relationship was rather tentative.
Second, a relatively limited number of variables was
examined; in addition to socio-demographic and clinical
data, a complex interaction of other factors, such as
self-esteem, premorbid adjustment, therapy and social
support network could also play a role in determining
subjective quality of life.
Finally, a potential limitation of the study was the use
of the WHOQOL-BREF, a generic questionnaire that
may not have detected subtle changes of subjective QoL
in the specific population of schizophrenia patients.
Conclusions
The World Health Organisation [34] reports that there
has been a worldwide pattern shift from hospital care to
community-based care of people with mental illnesses.
Italy has worked on decentralising its mental health ser-
vices since 1978. The present research on social func-
tioning, psychiatric symptoms and QoL in people with
schizophrenia suggests that symptoms, but, above all,
personal and social functioning are important elements
to determine QoL. These studies point to the impor-
tance of looking beyond symptom-reduction strategies
for improving QoL in schizophrenia; furthermore, they
underline how rehabilitation facilities and increased par-
ticipation of families and communities in the treatment
significantly improve quality of life of people with men-
tal illness.
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